Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G

• David J. Stanley ,

  Contributed equally to this work with: David J. Stanley, Koen Bartholomeeusen

  Affiliations Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America, Graduate Program in Biophysics, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Koen Bartholomeeusen ,

  Contributed equally to this work with: David J. Stanley, Koen Bartholomeeusen

  Affiliation Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• David C. Crosby,

  Affiliation Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Dong Young Kim,

  Affiliation Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Eunju Kwon,

  Affiliation Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Linda Yen,

  Affiliation Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Nathalie Caretta Cartozo,

  Affiliation Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Ming Li,

  Affiliation Department of Biochemistry, Molecular Biology and Biophysics, Institute for Molecular Virology, Center for Genome Engineering, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Stefanie Jäger,

  Affiliation Department of Molecular and Cellular Pharmacology, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Jeremy Mason-Herr,

  Affiliation Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Fumiaki Hayashi,

  Affiliation RIKEN Systems and Structural Biology Center, Tsurumi, Yokohama, Japan

  ⨯
• Shigeyuki Yokoyama,

  Affiliations RIKEN Systems and Structural Biology Center, Tsurumi, Yokohama, Japan, Department of Biophysics and Biochemistry, Graduate School of Science, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Nevan J. Krogan,

  Affiliations Department of Molecular and Cellular Pharmacology, University of California, San Francisco, San Francisco, California, United States of America, California Institute for Quantitative Biosciences, QB3, University of California, San Francisco, San Francisco, California, United States of America, J. David Gladstone Institutes, San Francisco, California, United States of America

  ⨯
• Reuben S. Harris,

  Affiliation Department of Biochemistry, Molecular Biology and Biophysics, Institute for Molecular Virology, Center for Genome Engineering, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Boris Matija Peterlin,

  Affiliation Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
•  [ ... ],
• John D. Gross

  * E-mail: jdgross@cgl.ucsf.edu

  Affiliations Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America, California Institute for Quantitative Biosciences, QB3, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• [ view all ]
• [ view less ]